Cargando…
Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution
PURPOSE: Medicines in special situations (MSS) refer to off‐label or to unlicensed drugs under investigation (compassionate use). Our objectives were to evaluate characteristics and to estimate overall survival (OS), event‐free survival (EFS), and the duration of treatment (DT) of MSS used for cance...
Autores principales: | Fontanals, Sandra, Esteve, Anna, González, Andrea, Ibáñez, Cristina, Martínez, Javier, Mesía, Ricard, Clopés, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501253/ https://www.ncbi.nlm.nih.gov/pubmed/37496404 http://dx.doi.org/10.1002/cam4.6360 |
Ejemplares similares
-
Understanding the challenges and ethical aspects of compassionate use of drugs in emergency situations
por: Goyal, Pardeep Kumar, et al.
Publicado: (2020) -
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic
por: Bassetti, Matteo, et al.
Publicado: (2020) -
Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study
por: Berlanga, Pablo, et al.
Publicado: (2023) -
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
por: Ku, Geoffrey Y, et al.
Publicado: (2010) -
Compassionate use of cell products
por: de Santis, Gil Cunha, et al.
Publicado: (2013)